[A double-blind nomifensine-nortriptyline trial in ambulatory patients conducted by psychiatrists in private practice: results and comments].
Nomifensine and nortriptyline were compared in a  collaborative trial by psychiatrists in private practice. The trial impiled:--selection of ambulatory depressed patients--randomization in parallel groups (respectively 31 and 34 subjects)--administration in double-blind condition of 4 capsuels daily of either compound during 4 weeks--quotation of depressvie syndrom with Hamilton depression scale before treatment after 2 and 4 weeks. The analysis of results shows clear improvment of depression scores, equivalent in both groups (non significant difference and posterior rejection of an alternative hypothesis). Practical problems encountered in controlled trials in psychiatrist's outpatients are discussed.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009627:Nomifensine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009661:Nortriptyline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013223:Statistics as Topic
D000928:Antidepressive Agents; D007546:Isoquinolines; D009627:Nomifensine; D009661:Nortriptyline
Un essai nomifensine-nortriptyline mené en double aveugle et en ambulatoire par des psychiatres praticiens. Résultats et commentaires.